Top Markets
Coin of the day
Abingdon Health Plc Abingdon Health Plc

Abingdon Health Plc

ABDX
Clasificación en acciones #39799
Established in 2008 and based in York, United Kingdom, Abingdon Health Plc is a... Established in 2008 and based in York, United Kingdom, Abingdon Health Plc is a global entity dedicated to the creation, production, and worldwide distribution of diagnostic instruments. Their product line features the AbC-19 Rapid Test, a fast-acting diagnostic for COVID-19 IgG antibodies, alongside various nucleic acid lateral flow immunoassays. They also offer Seralite, a swift lateral flow test for accurately measuring kappa and lambda immunoglobulin free light chains in blood serum. Additionally, their AppDx technology converts any smartphone into an autonomous and adaptable lateral-flow reader. Beyond these offerings, the company provides expert services in lateral flow development and manufacturing, as well as advisory support to firms in the health tech industry. Abingdon Health Plc also engages in a collaborative and co-marketing partnership with Abcam plc.
Precio por acción
$0.14967717
Capitalización bursátil
$378.31K
Cambio (1 día)
4.76%
Cambio (1 año)
77.02%
País
GB
Comercio Abingdon Health Plc (ABDX)

Categoría

EPS de Abingdon Health Plc (ABDX)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Abingdon Health Plc, el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Abingdon Health Plc desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras